Abstract
Objectives
The COVID-19 pandemic and ensuing public health emergency has emphasized the need to study SARS-CoV-2 pathogenesis. The human microbiome has been shown to regulate the host immune system and may influence host susceptibility to viral infection, as well as disease severity. Several studies have assessed whether compositional alterations in the nasopharyngeal microbiota are associated with SARS-CoV-2 infection. However, the results of these studies were varied, and many did not account for disease severity. This study aims to examine whether compositional differences in the nasopharyngeal microbiota are associated with SARS-CoV-2 infection status and disease severity.
Methods
We performed Nanopore full-length 16S rRNA sequencing on 194 nasopharyngeal swab specimens from hospitalized and community-dwelling SARS-CoV-2-infected and uninfected individuals. Sequence data analysis was performed using the BugSeq 16S analysis pipeline.
Results
We found significant beta (PERMANOVA p < 0.05), but not alpha (Kruskal-Wallis p > 0.05) diversity differences in the nasopharyngeal microbiota among our study groups. We identified several differentially abundant taxa associated with SARS-CoV-2 infection status and disease severity using ALDEx2. Finally, we observed a trend towards higher abundance of Enterobacteriaceae in specimens from hospitalized SARS-CoV-2-infected patients.
Conclusions
This study identified several alterations in the nasopharyngeal microbiome associated with SARS-CoV-2 infection status and disease severity. Understanding the role of the microbiome in infection susceptibility and severity may open new avenues of research for disease prevention and treatment.
Publisher
Public Library of Science (PLoS)
Reference29 articles.
1. The global and local distribution of RNA structure throughout the SARS-CoV-2 genome;CA Tavares R de;J Virol,2020
2. Influence of microbiota on viral infections;J Wilks;PLoS Pathog,2012
3. The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection;O Gallo;Mucosal Immunol,2021
4. Oral Microbiome and SARS-CoV-2: Beware of Lung Co-infection;L Bao;Front Microbiol,2020
5. Impact of the respiratory microbiome on host responses to respiratory viral infection;M Pichon;Vaccines,2017
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献